UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

IBS and IBD - separate entities or on a spectrum?

Nature reviews. Gastroenterology & hepatology, 2016-10, Vol.13 (10), p.613

2016

Volltextzugriff (PDF)

A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects

PloS one, 2018-07, Vol.13 (7), p.e0201410-e0201410

2018

Volltextzugriff (PDF)

The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls

International journal of molecular sciences, 2019-01, Vol.20 (2), p.433

2019

Volltextzugriff (PDF)

A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome

Scientific reports, 2022-02, Vol.12 (1), p.1949-1949, Article 1949

2022

Volltextzugriff (PDF)

Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome

Microbiology spectrum, 2023-10, Vol.11 (5), p.e0117523-e0117523

2023

Volltextzugriff (PDF)

Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection

Journal of clinical microbiology, 2016-11, Vol.54 (11), p.2689-2694

2016

Volltextzugriff (PDF)

368 Associations Between Microbiota, Colonic Volume and Transit and the Low FODMAP Diet With and Without Added Oligofructose

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S82-S82

2016

Volltextzugriff (PDF)

Su1577 MRI Shows Increased Water and Gas in the Bowel of Constipated Patients After Psyllium

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S531-S531

2016

Volltextzugriff (PDF)

Fermentable Carbohydrates in IBD - Trouble Brewing?

Journal of Crohn's and colitis, 2017-12, Vol.11 (12), p.1405-1406

Major, Giles

2017

Volltextzugriff (PDF)

A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study

NIHR open research, 2023-01, Vol.3, p.65

2023

Volltextzugriff (PDF)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome

Current opinion in endocrinology, diabetes, and obesity, 2014-02, Vol.21 (1), p.15-21

2014

Volltextzugriff (PDF)

246 A Double-Blind Crossover Study Using Magnetic Resonance Imaging Shows That Fructose and Inulin Mediate Symptoms in IBS Patients Through Different Mechanisms: Early Increase in Small Bowel Water Versus Late Increase in Colonic Gas

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-55-S-56

2015

Volltextzugriff (PDF)

Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis

Cochrane database of systematic reviews, 2021-08, Vol.8 (8), p.CD013488-CD013488

2021

Volltextzugriff (PDF)

Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome

Gastroenterology (New York, N.Y. 1943), 2017-01, Vol.152 (1), p.124-133.e2

2017

Volltextzugriff (PDF)

Su2056 Novel MRI Techniques and Parameters for Assessing the Impact of Laxatives on the Human Colon

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-534-S-534

2014

Volltextzugriff (PDF)

Dosing regimens for pancreatic enzyme replacement therapy (PERT) in cystic fibrosis

Cochrane database of systematic reviews, 2019-12, Vol.2019 (12)

2019

Volltextzugriff (PDF)

Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition

Gut, 2018-08, Vol.67 (8), p.1380

2018

Volltextzugriff (PDF)

A systematic Cochrane Review of the timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis [1]

Paediatric respiratory reviews, 2021-12, Vol.40, p.44-45

2021

Volltextzugriff (PDF)

Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery

Gut, 2023-03, Vol.72 (3), p.451

2023

Volltextzugriff (PDF)

Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies

Gut, 2022-05, Vol.71 (5), p.919

2022

Volltextzugriff (PDF)

Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis

Journal of cystic fibrosis, 2022-05, Vol.21 (3), p.506-513

2022

Volltextzugriff (PDF)

Contrasting effects of viscous and particulate fibers on colonic fermentation in vitro and in vivo, and their impact on intestinal water studied by MRI in a randomized trial

The American journal of clinical nutrition, 2020-09, Vol.112 (3), p.595-602

2020

Volltextzugriff (PDF)

Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls

Journal of cystic fibrosis, 2022-05, Vol.21 (3), p.502-505

2022

Volltextzugriff (PDF)

Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis

Journal of cystic fibrosis, 2024-05

2024

Volltextzugriff (PDF)

Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging

Journal of cystic fibrosis, 2021-07, Vol.20 (4), p.591-597

2021

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

KollektionProject MUSE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

IBS and IBD - separate entities or on a spectrum?

A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects

The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls

A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome

Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome

Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection

368 Associations Between Microbiota, Colonic Volume and Transit and the Low FODMAP Diet With and Without Added Oligofructose

Su1577 MRI Shows Increased Water and Gas in the Bowel of Constipated Patients After Psyllium

Fermentable Carbohydrates in IBD - Trouble Brewing?

A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study

Irritable bowel syndrome, inflammatory bowel disease and the microbiome

246 A Double-Blind Crossover Study Using Magnetic Resonance Imaging Shows That Fructose and Inulin Mediate Symptoms in IBS Patients Through Different Mechanisms: Early Increase in Small Bowel Water Versus Late Increase in Colonic Gas

Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis

Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome

Su2056 Novel MRI Techniques and Parameters for Assessing the Impact of Laxatives on the Human Colon

Dosing regimens for pancreatic enzyme replacement therapy (PERT) in cystic fibrosis

Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition

A systematic Cochrane Review of the timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis [1]

Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery

Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies

Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis

Contrasting effects of viscous and particulate fibers on colonic fermentation in vitro and in vivo, and their impact on intestinal water studied by MRI in a randomized trial

Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls

Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis

Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging

Aktive Filter

Suchergebnisse filtern